- Home
- WINT vs AEMD Comparison
WINT vs AEMD Comparison
Compare WINT & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- AEMD
- Stock Information
- Founded
- WINT 1992
- AEMD 1984
- Country
- WINT United States
- AEMD United States
- Employees
- WINT N/A
- AEMD N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- AEMD Medical/Dental Instruments
- Sector
- WINT Health Care
- AEMD Health Care
- Exchange
- WINT Nasdaq
- AEMD Nasdaq
- Market Cap
- WINT 1.8M
- AEMD 6.1M
- IPO Year
- WINT 1995
- AEMD N/A
- Fundamental
- Price
- WINT $0.99
- AEMD $0.38
- Analyst Decision
- WINT Hold
- AEMD Strong Buy
- Analyst Count
- WINT 1
- AEMD 1
- Target Price
- WINT $18.00
- AEMD $7.00
- AVG Volume (30 Days)
- WINT 1.7M
- AEMD 686.2K
- Earning Date
- WINT 11-07-2024
- AEMD 11-12-2024
- Dividend Yield
- WINT N/A
- AEMD N/A
- EPS Growth
- WINT N/A
- AEMD N/A
- EPS
- WINT N/A
- AEMD N/A
- Revenue
- WINT N/A
- AEMD N/A
- Revenue This Year
- WINT N/A
- AEMD N/A
- Revenue Next Year
- WINT N/A
- AEMD N/A
- P/E Ratio
- WINT N/A
- AEMD N/A
- Revenue Growth
- WINT N/A
- AEMD N/A
- 52 Week Low
- WINT $0.66
- AEMD $0.24
- 52 Week High
- WINT $23.58
- AEMD $2.35
- Technical
- Relative Strength Index (RSI)
- WINT 29.67
- AEMD 43.03
- Support Level
- WINT $1.04
- AEMD $0.41
- Resistance Level
- WINT $0.76
- AEMD $0.47
- Average True Range (ATR)
- WINT 0.18
- AEMD 0.03
- MACD
- WINT 0.13
- AEMD -0.01
- Stochastic Oscillator
- WINT 17.28
- AEMD 6.42
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.